These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 32130045)

  • 1. Invasive Intraductal Papillary Mucinous Neoplasms: CT Features of Colloid Carcinoma Versus Tubular Adenocarcinoma of the Pancreas.
    Fouladi DF; Raman SP; Hruban RH; Fishman EK; Kawamoto S
    AJR Am J Roentgenol; 2020 May; 214(5):1092-1100. PubMed ID: 32130045
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
    Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
    JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging comparison of tubular and colloid pancreatic adenocarcinoma arising from intraductal papillary mucinous neoplasm on multidetector CT.
    Escalon JG; Gerst S; Porembka M; Allen PJ; Do RK
    Clin Imaging; 2016; 40(6):1195-1199. PubMed ID: 27596236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between CT patterns and pathological classification of intraductal papillary mucinous neoplasm.
    Zhang J; Wang PJ; Yuan XD
    Eur J Radiol; 2010 Jan; 73(1):96-101. PubMed ID: 19008065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDCT of intraductal papillary mucinous neoplasm of the pancreas: evaluation of features predictive of invasive carcinoma.
    Kawamoto S; Lawler LP; Horton KM; Eng J; Hruban RH; Fishman EK
    AJR Am J Roentgenol; 2006 Mar; 186(3):687-95. PubMed ID: 16498096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary mucinous neoplasms of the pancreas: correlation of helical CT features with pathologic findings.
    Liu Y; Lin X; Upadhyaya M; Song Q; Chen K
    Eur J Radiol; 2010 Nov; 76(2):222-7. PubMed ID: 19586733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic intraductal papillary mucinous neoplasms: role of CT in predicting pathologic subtypes.
    Gupta R; Mortelé KJ; Tatli S; Girshman J; Glickman JN; Levy AD; Erturk SM; Heffess CS; Banks PA; Silverman SG
    AJR Am J Roentgenol; 2008 Nov; 191(5):1458-64. PubMed ID: 18941085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive carcinomas originating from intraductal papillary mucinous neoplasms of the pancreas: conspicuity and primary sites of the solid masses on triple-phase dynamic CT imaging.
    Yamada Y; Mori H; Matsumoto S; Hijiya N; Hongo N; Moriyama M
    Abdom Imaging; 2010 Apr; 35(2):181-8. PubMed ID: 19777289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Invasive Intraductal Papillary Mucinous Carcinoma of the Pancreas.
    Hirono S; Kawai M; Okada KI; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    JAMA Surg; 2017 Mar; 152(3):e165054. PubMed ID: 28122068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of multidetector-row computed tomography to evaluate branch duct type intraductal papillary mucinous neoplasms of the pancreas: influence on surgical decision-making.
    Ishii H; Taniguchi H; Shiozaki A; Kuriu Y; Ikoma H; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sakakura C; Sonoyama T; Otsuji E
    Hepatogastroenterology; 2012 May; 59(115):884-8. PubMed ID: 22020905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lateral spread along the main pancreatic duct in branch-duct intraductal papillary-mucinous neoplasms of the pancreas: usefulness of intraductal ultrasonography for its evaluation.
    Kobayashi G; Fujita N; Noda Y; Ito K; Horaguchi J; Obana T; Koshida S; Kanno Y; Yamashita Y; Kato Y; Ogawa T; Sawai T
    Dig Endosc; 2011 Jan; 23(1):62-8. PubMed ID: 21198919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interobserver agreement for detection of malignant features of intraductal papillary mucinous neoplasms of the pancreas on MDCT.
    Do RK; Katz SS; Gollub MJ; Li J; LaFemina J; Zabor EC; Moskowitz CS; Klimstra DS; Allen PJ
    AJR Am J Roentgenol; 2014 Nov; 203(5):973-9. PubMed ID: 25341134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Main duct and mixed type intraductal papillary mucinous neoplasms without enhancing mural nodules: Duct diameter of less than 10 mm and segmental dilatation of main pancreatic duct are findings support surveillance rather than immediate surgery.
    Kim TH; Song TJ; Lee SO; Park CH; Moon JH; Pih GY; Oh DW; Woo SM; Yang YJ; Kim MH
    Pancreatology; 2019 Dec; 19(8):1054-1060. PubMed ID: 31611130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
    Adsay NV; Conlon KC; Zee SY; Brennan MF; Klimstra DS
    Cancer; 2002 Jan; 94(1):62-77. PubMed ID: 11815961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of intraductal papillary mucinous neoplasms of the pancreas on MDCT and MRI].
    Wang D; Zhou J; Zheng S; Xia J; Hu H
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):682-7. PubMed ID: 25564059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
    Roch AM; Barron MR; Tann M; Sandrasegar K; Hannaford KN; Ceppa EP; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    J Am Coll Surg; 2015 Jul; 221(1):48-56. PubMed ID: 26095551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
    Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
    Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.